Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer
Author:
Affiliation:
1. Department of Medicine, Georgetown University, Washington, DC
2. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC
3. Division of Hematology and Oncology, Georgetown University, Washington, DC
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
http:///jamaoncology/article-pdf/5/7/1049/17712520/jamaoncology_cook_2019_rv_180011.pdf
Reference43 articles.
1. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.;Jones;MMWR CDC Surveill Summ,1999
2. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.;Palella;J Acquir Immune Defic Syndr,2006
3. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.;Palella;N Engl J Med,1998
4. HIV-associated cancers and related diseases.;Yarchoan;N Engl J Med,2018
5. Drug interactions between antineoplastic and antiretroviral therapies: implications and management for clinical practice.;Mounier;Crit Rev Oncol Hematol,2009
Cited by 178 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current Advances and Challenges in the Management of Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients;Cancers;2024-09-10
2. Cancer in People with HIV;Infectious Disease Clinics of North America;2024-09
3. Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States;Clinical Lymphoma Myeloma and Leukemia;2024-08
4. Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study;Journal for ImmunoTherapy of Cancer;2024-08
5. Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies;Cancer Communications;2024-07-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3